Key points are not available for this paper at this time.
Evidence of a possible small benefit from PSA screening supports a grade C recommendation — not the U.S. Preventive Services Task Force's proposed grade D — for men 55 to 69 years of age, who should participate in screening decisions after discussion with a primary care provider.
McNaughton‐Collins et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: